Inno-Gene Balance Sheet Health
Financial Health criteria checks 4/6
Inno-Gene has a total shareholder equity of PLN2.8M and total debt of PLN30.0K, which brings its debt-to-equity ratio to 1.1%. Its total assets and total liabilities are PLN5.5M and PLN2.7M respectively.
Key information
1.1%
Debt to equity ratio
zł30.00k
Debt
| Interest coverage ratio | n/a |
| Cash | zł1.59m |
| Equity | zł2.81m |
| Total liabilities | zł2.69m |
| Total assets | zł5.50m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: WQ3's short term assets (PLN3.0M) exceed its short term liabilities (PLN2.5M).
Long Term Liabilities: WQ3's short term assets (PLN3.0M) exceed its long term liabilities (PLN203.0K).
Debt to Equity History and Analysis
Debt Level: WQ3 has more cash than its total debt.
Reducing Debt: WQ3's debt to equity ratio has reduced from 24.2% to 1.1% over the past 5 years.
Debt Coverage: WQ3's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if WQ3's interest payments on its debt are well covered by EBIT.